Arteriosclerosis and Thrombosis, Vol 13, 1551-1557, Copyright © 1993 by American Heart Association
ARTICLES |
BJ Warn-Cramer and SI Rapaport
Department of Medicine, School of Medicine, University of California at San Diego, La Jolla.
In earlier studies from this laboratory evidence was obtained for a physiological function of tissue factor pathway inhibitor (TFPI) as a regulator of hemostasis capable of preventing thrombotic complications that might otherwise result from exposure of blood to trace amounts of tissue factor (TF). However, it was not possible to conclude that the protective effect of TFPI stemmed solely from inhibition of factor VIIa/TF catalytic activity, since TFPI neutralizes stoichiometric amounts of factor Xa in forming an inhibited factor Xa/TFPI/factor VIIa/TF complex. Therefore, we examined the effects of immunodepletion of TFPI on the extent of coagulation initiated in rabbits by exposure to factor Xa and phospholipid in the absence of TF. In one experimental approach, factor Xa was generated endogenously with the factor X- activating fraction of Russell's viper venom (0.33 microgram/kg) in rabbits receiving an infusion of phosphatidylcholine/phosphatidylserine (PCPS) vesicles, 1 mg/kg over 2 hours. In a second approach, rabbits were injected with a complex of factor Xa (0.75 microgram/kg) and PCPS (12.5 micrograms/kg). In contrast with the observed sensitization of TFPI-depleted rabbits to TF-induced coagulation, TFPI-depleted rabbits were not sensitized to coagulation initiated by factor Xa and phospholipid in the absence of TF. These data support the conclusion that the physiological function of TFPI in regulating TF-dependent coagulation stems primarily from its ability to inhibit factor VIIa/TF catalytic activity.
This article has been cited by other articles:
![]() |
Z.-F. Huang, D. Higuchi, N. Lasky, and G. J. Broze Jr Tissue Factor Pathway Inhibitor Gene Disruption Produces Intrauterine Lethality in Mice Blood, August 1, 1997; 90(3): 944 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Rapaport, T. Toneff, A. Rimon, and B. J. Warn-Cramer The Effect of Immunodepletion of Antithrombin III on the Response of Rabbits to Russell's Viper Venom–Induced Activation of Factor X Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 409 - 416. [Abstract] [Full Text] |
||||
![]() |
G. S. Abela, P. D. Picon, S. E. Friedl, O. C. Gebara, A. Miyamoto, M. Federman, G. H. Tofler, and J. E. Muller Triggering of Plaque Disruption and Arterial Thrombosis in an Atherosclerotic Rabbit Model Circulation, February 1, 1995; 91(3): 776 - 784. [Abstract] [Full Text] |
||||
![]() |
B. J. Warn-Cramer and S. I. Rapaport Evidence Suggestive of Activation of the Intrinsic Pathway of Blood Coagulation After Injection of Factor Xa/Phospholipid Into Rabbits Arterioscler Thromb Vasc Biol, January 1, 1995; 15(1): 133 - 139. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |